Furthermore, ccr5 deficiency imposes restrictions on atherosclerotic plaque formation in atherosclerosis-prone mice by reducing the systemic immuno-inflammatory response and contributing to large changes in lesion composition during the initial stages of plaque development (18, 19). This evidence concerns the gene CCR5 and atherosclerosis.